Synergium Sweden AB is a Life Science translation company with a dedicated focus on the fast-paced and complex industry of Life Science. With a team of 55 professionals across 5 countries and a Customer Excellence Team in Sweden, the company has been providing translation services to pharma, medtech, biotech, and healthcare companies since 2005. Their specialization and passion in this sector enable them to deliver accurately translated text by subject matter experts, catering specifically to the medical industry's stringent regulations and tight deadlines.
The company prides itself on its certifications, including ISO 14971:2012 for Life Science Services Risk Management, ISO 9001:2015 for Total Quality Management Systems, ISO 27001:2013 for Information Systems Security, ISO 13485:2012 for Life Science Services Quality, and ISO 17100:2015 for Translation Quality. Their mission, "Specialized life science translations save lives," encapsulates the meaningful impact of their work.
For venture capital investors, Synergium Sweden AB presents an opportunity to support a specialized medical translation company that has demonstrated its commitment to quality, compliance, and the global reach of innovative medical products. With a focus on supporting the growth of the healthcare industry, the company's track record and industry-specific expertise position it as a potential long-term partner for companies seeking to navigate diverse regulations and reach international markets.